In Silico Oncology: Quantification of the In Vivo Antitumor Efficacy of Cisplatin-Based Doublet Therapy in Non-Small Cell Lung Cancer (NSCLC) through a Multiscale Mechanistic Model

The 5-year survival of non-small cell lung cancer patients can be as low as 1% in advanced stages. For patients with resectable disease, the successful choice of preoperative chemotherapy is critical to eliminate micrometastasis and improve operability. In silico experimentations can suggest the opt...

Descripción completa

Detalles Bibliográficos
Autores principales: Kolokotroni, Eleni, Dionysiou, Dimitra, Veith, Christian, Kim, Yoo-Jin, Sabczynski, Jörg, Franz, Astrid, Grgic, Aleksandar, Palm, Jan, Bohle, Rainer M., Stamatakos, Georgios
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2016
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5033576/
https://www.ncbi.nlm.nih.gov/pubmed/27657742
http://dx.doi.org/10.1371/journal.pcbi.1005093

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5033576/
https://www.ncbi.nlm.nih.gov/pubmed/27657742
http://dx.doi.org/10.1371/journal.pcbi.1005093

Ejemplares similares